Issue
Alert me when new journal issues are available via or via
Preface A.H. Barnett, C.J. Bailey pages vii-viii Full Text | Full-Text PDF (41 KB)
Incretin hormone mimetics and analogues in diabetes therapeutics Brian D. Green, Peter R. Flatt pages 497-516 Abstract | Full Text | Full-Text PDF (316 KB)
DPP-4 inhibitors Bo Ahrén pages 517-533 Abstract | Full Text | Full-Text PDF (516 KB)
Cannabinoid-1 receptor antagonists in type-2 diabetes André J. Scheen pages 535-553 Abstract | Full Text | Full-Text PDF (751 KB)
Inhaled insulin Sabine Arnolds, Tim Heise pages 555-571 Abstract | Full Text | Full-Text PDF (564 KB)
PKC inhibition and diabetic microvascular complications Margaret Clarke, Paul M. Dodson pages 573-586 Abstract | Full Text | Full-Text PDF (524 KB)
New hepatic targets for glycaemic control in diabetes Loranne Agius pages 587-605 Abstract | Full Text | Full-Text PDF (292 KB)
Modulation of glucocorticoid action and the treatment of type-2 diabetes Jeremy W. Tomlinson, Paul M. Stewart pages 607-619 Abstract | Full Text | Full-Text PDF (344 KB)
Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus Shlomit Koren, I. George Fantus pages 621-640 Abstract | Full Text | Full-Text PDF (613 KB)
Potential therapies based on antidiabetic peptides Tom Billyard, Philip McTernan, Sudhesh Kumar pages 641-655 Abstract | Full Text | Full-Text PDF (288 KB)
Pharmaco-economic issues for diabetes therapy Julia M. Bottomley, Frank D. Raymond pages 657-685 Abstract | Full Text | Full-Text PDF (596 KB)
PPAR agonists: multimodal drugs for the treatment of type-2 diabetes Barbara Gross, Bart Staels pages 687-710 Abstract | Full Text | Full-Text PDF (268 KB)
Keyword Index page I1 Full-Text PDF (58 KB)
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
